Best Practices for Managing Pseudofolliculitis Barbae
JAMA Dermatology · 23.09.2026
DOI: 10.1001/jamadermatol.2026.3579 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, online erschienen am 23.09.2026. Verfasst von Simona A Alomary und 19 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers New Jersey Medical School, Newark, New Jersey. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Importance Pseudofolliculitis barbae (PFB) is a chronic inflammatory disease caused by penetration of a shaved, curved hair shaft into the skin. Standardized recommendations for diagnosing and managing PFB are needed.
Objective
To establish expert consensus recommendations outlining best practices for diagnosing and managing PFB. Evidence Review A 3-round Delphi consensus study was conducted using a panel of board-certified US dermatologists with expertise in PFB. Consensus statements addressing diagnostic criteria, behavioral modification, topical and systemic therapies, procedural interventions, and occupational considerations were developed and evaluated using a 9-point Likert scale. Consensus was predefined as greater than or equal to 75% agreement.
Findings
Forty statements associated with diagnostic criteria, medical and procedural management, and occupational considerations reached consensus. Behavioral modification of hair removal practices as first-line therapy, use of targeted topical and systemic treatments, and procedural interventions, such as laser hair removal, were supported. No agreement was reached regarding a standardized grading scale, the use of oral isotretinoin for refractory disease, superficial chemical peels, or the use of multiblade razors. Conclusions and Relevance Using a Delphi consensus study approach, expert consensus guidelines were established for diagnosing and managing PFB. These recommendations provide an evidence-informed framework to support clinical decision-making, guide future research efforts, and help inform policy considerations associated with PFB management.
Autor:innen und Institutionen
- Rutgers New Jersey Medical School, Newark, New Jersey.
- Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
- Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania.
- Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles.
- Meharry Medical College, Nashville, Tennessee.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Zitieren
APA
Alomary, S. A., Baker, N. J., Ugwueke, G., Alkiswani, H., Adotama, P., Awosika, O., Burgess, C., Callender, V., Cho, S., Downie, J., Ibrahimi, O., Ludzik, J., Mayo, T., Mitchell, H., Ogunleye, T., Ritchie, S., Yu, J., Lyford, W. H., Elbuluk, N., & Taylor, S. C. (2026). Best Practices for Managing Pseudofolliculitis Barbae. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2026.3579
Vancouver
Alomary SA, Baker NJ, Ugwueke G, Alkiswani H, Adotama P, Awosika O, et al. Best Practices for Managing Pseudofolliculitis Barbae. JAMA Dermatology. 2026. doi:10.1001/jamadermatol.2026.3579
BibTeX
@article{Alomary2026,
author = {Alomary, Simona A and Baker, Nicole J and Ugwueke, Grace and Alkiswani, Haya and Adotama, Prince and Awosika, Olabola and Burgess, Cheryl and Callender, Valerie and Cho, Sunghun and Downie, Jeanine and Ibrahimi, Omar and Ludzik, Joanna and Mayo, Tiffany and Mitchell, Hope and Ogunleye, Temitayo and Ritchie, Simon and Yu, JiaDe and Lyford, Willis H and Elbuluk, Nada and Taylor, Susan C},
title = {Best Practices for Managing Pseudofolliculitis Barbae},
journal = {JAMA Dermatology},
year = {2026},
doi = {10.1001/jamadermatol.2026.3579}
}
EUVIMED